---
id: idsa-meningitis-2024
title: "IDSA 2024 Clinical Practice Guideline: Bacterial Meningitis in Adults"
short_title: "IDSA Bacterial Meningitis 2024"

organization: Infectious Diseases Society of America
collaborators: null
country: US
url: https://www.idsociety.org/guidelines/
doi: null
pmid: null
open_access: true

specialty: infectious-disease
guideline_type: clinical-practice
evidence_system: IDSA GRADE
conditions:
  - bacterial meningitis
  - meningitis
  - CNS infection
tags:
  - ceftriaxone
  - vancomycin
  - dexamethasone
  - lumbar puncture
  - empiric therapy

publication_date: 2024-07-01
previous_version_date: 2017-07-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 IDSA guideline update on the diagnosis and treatment of acute bacterial meningitis in adults.

## Key Recommendations

### Clinical Presentation
- Classic triad: Fever, nuchal rigidity, altered mental status (present in ~50%).
- Headache, photophobia, nausea/vomiting, seizures.

### Diagnosis
- **Lumbar Puncture (LP)**: Essential. Obtain CSF before antibiotics if no delay; otherwise give antibiotics first and LP ASAP after.
- CSF findings: Elevated WBC (neutrophil predominance), high protein, low glucose, positive Gram stain/culture.
- **Multiplex PCR Panels**: Rapid identification of pathogens.
- Blood cultures in all patients.

### Empiric Antibiotic Therapy (Start Immediately)
- **Adults <50 years**: Ceftriaxone + Vancomycin.
- **Adults ≥50 years or Immunocompromised**: Ceftriaxone + Vancomycin + Ampicillin (for Listeria coverage).
- Adjust based on Gram stain and culture results.

### Adjunctive Dexamethasone
- **Recommended**: 0.15 mg/kg IV q6h x 4 days, starting with or just before first dose of antibiotics.
- Greatest benefit in pneumococcal meningitis (reduces mortality and neurologic sequelae).
- May discontinue if non-pneumococcal etiology confirmed.

### Pathogen-Specific Therapy
- **S. pneumoniae**: Ceftriaxone or cefotaxime; add vancomycin if penicillin-resistant.
- **N. meningitidis**: Ceftriaxone or penicillin G.
- **L. monocytogenes**: Ampicillin (± gentamicin).
- **GBS, H. influenzae, Gram-Negative Bacilli**: Per susceptibility.

### Duration
- Depends on pathogen: 7-14 days for most; 21 days for Listeria or gram-negative bacilli.

### Chemoprophylaxis (Close Contacts)
- **Meningococcal Meningitis**: Rifampin, ciprofloxacin, or ceftriaxone for close contacts.
